Skip to main content

Jury Cleared J&J & Colgate In Travel Agent’s Talc Lawsuit

Jury Cleared J&J & Colgate In Travel Agent’s Talc Lawsuit

Jury Cleared J&J & Colgate In Travel Agent’s Talc Lawsuit

Introduction

On Friday, a Kentucky jury after less than an hour of deliberations cleared Johnson & Johnson (J&J) and Colgate-Palmolive over claims that their talcum powder caused the now deceased plaintiff's mesothelioma.

According to the plaintiff's lawyer Joseph Satterley,  the plaintiff, born in 1944, started using Colgate-Palmolive’s Cashmere Bouquet Powder in 1962 and was diagnosed with mesothelioma in April 2016. She had a career as a travel agent in the 1970s. Satterley, also stated that the powders were full of asbestos and according to the documents, an FDA analysis told Colgate in 1976 that their powder was “loaded” with tremolite fibers.

This was J&J's sixth win in recent months. In a similar trial conducted in June, both the companies paid $12 million to plaintiff a plaintiff. The jury found J&J 30% responsible and Colgate 40% responsible for the plaintiff’s cancer.

Talc defendants currently face nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits, consolidated under multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), in the District of New Jersey. The MDL is presided by Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!